VIRACEPT (PD-Rx Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the VIRACEPT drug offered from PD-Rx Pharmaceuticals, Inc.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: PD-Rx Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: nelfinavir mesylate
SUBSTANCE NAME: NELFINAVIR MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-03-14
END MARKETING DATE: 0000-00-00


VIRACEPT HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVIRACEPT from PD-Rx Pharmaceuticals, Inc.
LABELER NAME: PD-Rx Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 1997-03-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55289-477_4a5388f1-5d84-63cb-e054-00144ff88e88
PRODUCT NDC: 55289-477
APPLICATION NUMBER: NDA020779

Other NELFINAVIR MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AGOURONVIRACEPT
H.J. Harkins Company, Inc.VIRACEPT
PD-Rx Pharmaceuticals, Inc.VIRACEPT
State of Florida DOH Central PharmacyViracept